new guidelines for treating chronic obstructive pulmonary disease (COPD)

Canadian experts just released new guidelines for treating chronic obstructive pulmonary disease (COPD).

They recommend an inhaled anticholinergic (ipratropium) for initial therapy...along with a short-acting beta-agonist (salbutamol, fenoterol).

A long-acting beta-agonist (salmeterol, formoterol) is recommended for patients who require substantial amounts of short-acting beta-agonists...or for patients who have prominent symptoms at night or early in the morning.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote